13-HODE inhibits the intracellular calcium increase of activated human polymorphonuclear cells.

Autor: van de Velde MJ; Department of Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, The Netherlands., Engels F, Henricks PA, Nijkamp FP
Jazyk: angličtina
Zdroj: Journal of leukocyte biology [J Leukoc Biol] 1994 Aug; Vol. 56 (2), pp. 200-2.
DOI: 10.1002/jlb.56.2.200
Abstrakt: We studied the effect of the linoleic acid metabolite 13-hydroxyoctadecadienoic acid (13-HODE) on the increase of the intracellular calcium concentration, [Ca2+]i, induced by platelet-activating factor (PAF), leukotriene B4 (LTB4), and formyl-Met-Leu-Phe (fMLP) in human polymorphonuclear leukocytes (PMNs). 13-HODE by itself did not change the [Ca2+]i of PMNs. However, when PMNs were preincubated with 13-HODE and subsequently stimulated with PAF, LTB4, or fMLP, an inhibition of the increase of the [Ca2+]i was observed. The PAF-induced calcium response was concentration-dependently inhibited between 0.1 and 5 microM 13-HODE. These results suggest that 13-HODE can affect the increase of the [Ca2+]i and hence can modulate activation of PMNs.
Databáze: MEDLINE